Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$6.15 USD
+0.06 (0.99%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $6.15 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Capricor Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Products industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CAPR 6.15 +0.06(0.99%)
Will CAPR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CAPR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CAPR
Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates
FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks
CAPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
Capricor Therapeutics (CAPR) Reports Q4 Loss, Tops Revenue Estimates
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates
Other News for CAPR
Is CAPR ready to move lower? Fell Below 20 Day Moving Average shows up after plummeting 8.42%
20 Day Moving Average Support appears for CAPR after 3.91% move
CAPR Crossed Above 20 Day Moving Average on September 19
CAPR forms Bollinger Band Squeeze on September 17
Is CAPR building pressure? Bollinger Band Squeeze shows up after rising 2.98%